Levodopa Pharmacokinetics and Motor Performance During Activities of Daily Living in Patients With Parkinson's Disease on Individual Drug Combinations
- 1 March 2002
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Neuropharmacology
- Vol. 25 (2), 89-96
- https://doi.org/10.1097/00002826-200203000-00006
Abstract
Pharmacokinetics and pharmacodynamics of levodopa were evaluated at a high-resolution level in a heterogeneous group of 10 patients with idiopathic Parkinson's disease during their normal daily activity. A physician and a nurse spent 10 hours with each patient from the first morning dose of levodopa during daily activities at home and at work. Plasma samples were obtained every 20 minutes for analysis of levodopa and 3-O-methyldopa by high-performance liquid chromatography. To assess clinical response, mobility was rated on every test occasion by patients and by investigators. Food and fluid intake and physical activity were also monitored. There was a large intra- and interindividual variability in the pharmacokinetics of levodopa regardless of the different drug combinations used. Mean plasma levodopa concentration ranged between 0.45 to 7.07 μg/mL and peak concentrations between 0.95 to 13.75 μg/mL. In 44 of 58 dosing events, an oral dose of levodopa was related to a peak in plasma concentration. Assessment of the clinical effects was more sensitive when given by patients than when given by the investigators. The fluctuations of the levodopa concentration in plasma had a clear effect on the clinical parameters assessed, even during early disease stages. Variation in levodopa concentration is the determining factor for motor fluctuations also in patients on clinically optimized combinations with dopamine agonists and enzyme inhibitors.Keywords
This publication has 21 references indexed in Scilit:
- Long-term intraduodenal infusion of a water based levodopa-carbidopa dispersion in very advanced Parkinson's diseaseActa Neurologica Scandinavica, 2009
- Outcome of Unilateral and Bilateral Pallidotomy for Parkinson's Disease: Patient AssessmentNeurosurgery, 2000
- PDQ-39: a review of the development, validation and application of a Parkinson’s disease quality of life questionnaire and its associated measuresZeitschrift für Neurologie, 1998
- The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease.Drugs, 1998
- The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index scoreAge and Ageing, 1997
- The effect of L‐leucine on the absorption of levodopa, studied by regional jejunal perfusion in man.British Journal of Clinical Pharmacology, 1993
- Treatment of Motor Fluctuations in Parkinsonʼs Disease with an Oral Sustained-Release Preparation of L-DopaClinical Neuropharmacology, 1986
- Human interdigestive and postprandial gastrointestinal motor and gastrointestinal hormone patternsDigestive Diseases and Sciences, 1982
- On‐off responseNeurology, 1975
- ParkinsonismNeurology, 1967